{"entity":{"id":"inovio","kind":"company","name":"Inovio Pharmaceuticals","aka":["Inovio","INOVIO Pharmaceuticals, Inc."],"tldr":"Inovio is a US company developing DNA medicines delivered by electroporation, whose lead cancer-related programme VGX-3100 treats the HPV-caused precancerous cervical lesions that lead to cervical cancer.","summary":"Inovio Pharmaceuticals, listed on Nasdaq, develops DNA plasmid immunotherapies and vaccines delivered into muscle or skin with a hand-held electroporation device. Its most advanced programme, VGX-3100, targets HPV 16 and 18 to clear high-grade cervical dysplasia (CIN2/3), the precancerous lesion that precedes cervical cancer, and completed the phase 3 REVEAL trials; the company has also run trials of DNA vaccines in HPV-related head and neck and anal cancers and in glioblastoma. It appears on OnCo as a lead sponsor of phase 3 cancer trials on ClinicalTrials.gov.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.inovio.com"},{"label":"ClinicalTrials.gov: trials led by Inovio Pharmaceuticals","url":"https://clinicaltrials.gov/search?lead=Inovio%20Pharmaceuticals"},{"label":"Wikipedia","url":"https://en.wikipedia.org/wiki/Inovio_Pharmaceuticals"}],"tags":["ctgov-sponsor"],"related":[],"cancers":["cervical","head-and-neck","glioblastoma"],"sections":["prevention","immunotherapy"],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Plymouth Meeting, PA","country":"US","companyType":"biotech","website":"https://www.inovio.com","stage":"public","investors":[],"funding":[]},"route":"/companies/inovio/","neighbours":{"cancer":[{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"},{"id":"glioblastoma","kind":"cancer","name":"Glioma & glioblastoma","route":"/cancers/glioblastoma/"},{"id":"head-and-neck","kind":"cancer","name":"Head and neck squamous cell carcinoma","route":"/cancers/head-and-neck/"}],"section":[{"id":"immunotherapy","kind":"section","name":"Immunotherapy","route":"/fronts/immunotherapy/"},{"id":"prevention","kind":"section","name":"Prevention & Risk","route":"/fronts/prevention/"}]}}